C-reactive protein in liver cancer surgery

European Journal of Surgical Oncology

Volumn 34, Issue 7, 2008, Pages 727-729

  Morris Stiff, G ^a   Gomez, D ^a   Prasad, K R ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

C reactive protein; Colorectal liver metastases; Hepatocellular carcinoma; Liver resection

Indexed keywords

C REACTIVE PROTEIN;

CANCER STAGING; CANCER SURGERY; COLORECTAL CANCER; CORRELATION ANALYSIS; HUMAN; INFORMATION RETRIEVAL; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; POSTOPERATIVE PERIOD; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; TREATMENT OUTCOME;

ACUTE-PHASE REACTION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARCINOMA, HEPATOCELLULAR; COLORECTAL NEOPLASMS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; PROGNOSIS;

EID: 51749126004     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.01.016     Document Type: Review

References (24)

1. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539-545
2. Tillett W.S., and Francis Jr. T. Serological reactions in pneumonia with a non-protein fraction of pneumococcus. J Exp Med 52 (1930) 561-571
3. Hurlimann J., Thorbecke G.J., and Hochwald G.M. The liver as the site of C-reactive protein formation. J Exp Med 123 (1966) 365-378
4. Mackiewicz A., Speroff T., Ganapathi M.K., and Kushner I. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol 146 (1991) 3032-3037
5. McMillan D.C., Wootherspoon H.A., Feraon K.C., Sturgeon C., Cooke T.G., and McArdle C.S. A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 170 (1995) 319-322
6. McMillan D.C., Canna K., and McArdle C.S. Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 90 (2003) 215-219
7. Erlinger T., Platz E., Rifai N., and Helzlsouer K.J. C-reactive protein and the risk of incident colorectal cancer. J Am Med Assoc 291 (2004) 585-590
8. Il'yasova D., Colbert L.H., Harris T.B., et al. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev 14 (2005) 2413-2418
9. Zhang S.M., Buring J.E., Lee I.M., Cook N.R., and Ridker P.M. C-reactive protein levels are not associated with increased risk for colorectal cancer in women. Ann Intern Med 142 (2005) 425-432
10. Ito Y., Suzuki K., Tamakoshi K., et al. Colorectal cancer and serum C-reactive protein levels: a case-control study nested in the JACC study. J Epidemiol 15 Suppl. 2 (2005) S185-S199
11. Ali A.A., McMillan D.C., Matalka I.I., McNicol A.M., and McArdle C.S. Tumour T-lymphocyte subset infiltration and tumour recurrence following curative resection for colorectal cancer. Eur J Surg Oncol 30 (2004) 292-295
12. Canna K., McArdle P.A., McMillan D.C., et al. The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer 92 (2005) 651-654
13. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., and Coffman R.L. Two types of murine helper T cell clones. Definition according to profiles of lymphokine activity and secreted proteins. J Immunol 136 (1986) 2348-2357
14. Scheller J., Ohnesorge N., and Rose-John S. Interluekin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol 63 (2006) 321-329
15. de Jong K.P., Hoedemakers R.M.J., Fidler V., et al. Portal and systemic serum growth factor and acute-phase response after laparotomy or partial hepatectomy in patients with colorectal liver metastases: a prognostic role for C-reactive protein and hepatocyte growth factor. Scand J Gastroenterol 39 (2004) 1141-1148
16. de Jong K.P., von Geusau1 B.A., Rottier C.A., et al. Serum response of hepatocyte growth factor, insulin-like growth factor-I, interleukin-6, and acute phase proteins in patients with colorectal liver metastases treated with partial hepatectomy or cryosurgery. J Hepatol 34 (2001) 422-427
17. Wong V.K., Malik H.Z., Hamady Z.Z., et al. C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. Br J Cancer 96 2 (2007) 222-225
18. Rahman SH, Evans J, Toogood GJ, Lodge JPA, Prasad KR. Post-operative C-reactive protein and post-hepatectomy liver failure. Arch Surg, in press.
19. Rifai N., Tracy R.P., and Ridker P.M. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 45 (1999) 2136-2141
20. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
21. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
22. Kao P.C., Shiesh S.C., and Wu T.J. Serum C-reactive protein as a marker of wellness assessment. Ann Clin Lab Sci 36 (2006) 163-169
23. Hashimoto K., Ikeda Y., Korenaga D., et al. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 103 (2005) 1856-1864
24. Lan A.K.-M., Luk H.-N., Goto S., et al. Stress response to hepatectomy in patients with a healthy or a diseased liver. World J Surg 27 (2003) 761-764